Adiponectin Controls the Mitochondrial Peptide MOTS-c Through a Specific Signaling Pathway

Adiponectin regulates MOTS-c production through the APPL1-SIRT1-PGC-1α pathway, and exercise restores this connection disrupted by obesity.

Guo, Qi et al.·Diabetologia·2020·Moderate EvidenceAnimal study (mice) + in vitro
RPEP-04833Animal study (mice) + in vitroModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal study (mice) + in vitro
Evidence
Moderate Evidence
Sample
C57BL/6 mice (wild-type and adiponectin knockout) on high-fat diet; C2C12 myotubes
Participants
C57BL/6 mice (wild-type and adiponectin knockout) on high-fat diet; C2C12 myotubes

What This Study Found

In mice lacking the adiponectin gene (Adipoq-/- knockouts), MOTS-c levels in blood and muscle were significantly lower than normal. This directly links adiponectin to MOTS-c production.

In muscle cells (C2C12 myotubes), adiponectin treatment increased MOTS-c gene expression. The researchers traced the signaling chain: adiponectin activates APPL1, which activates SIRT1, which activates PGC-1alpha, which drives MOTS-c production. Blocking any step in this chain (with inhibitors or siRNA) stopped the MOTS-c increase.

In mice on a high-fat diet, both exercise and injected adiponectin or MOTS-c raised MOTS-c levels in blood and muscle. This was accompanied by improved insulin sensitivity, suggesting MOTS-c is a key mediator of adiponectin's metabolic benefits.

Overexpressing SIRT1 amplified the adiponectin effect on MOTS-c, while blocking PGC-1alpha eliminated it. This establishes the APPL1-SIRT1-PGC-1alpha pathway as the mechanism.

Key Numbers

Adipoq-/- mice: lower MOTS-c; HFD: reduced MOTS-c; exercise and Acrp30 injection: restored MOTS-c; APPL1-SIRT1-PGC-1α pathway confirmed

How They Did This

Tested in mice and cell cultures. Used wild-type C57BL/6 mice on high-fat diet, adiponectin knockout mice, and C2C12 muscle cell cultures. Interventions included exercise, injected adiponectin (Acrp30), injected MOTS-c, gene overexpression, siRNA knockdown, and pharmacological inhibitors. Measured MOTS-c mRNA and protein levels, insulin sensitivity markers, and pathway components.

Why This Research Matters

MOTS-c is a relatively new discovery: a peptide encoded by mitochondrial DNA that influences metabolism. This study reveals how the body naturally regulates MOTS-c production through adiponectin signaling. It positions MOTS-c as a potential drug target for type 2 diabetes and explains part of why exercise improves insulin sensitivity.

The Bigger Picture

MOTS-c is generating excitement as a potential anti-aging and metabolic therapy. This study reveals how the body naturally regulates MOTS-c production, connecting the adiponectin-exercise-mitochondria axis. Understanding this regulation is essential for developing MOTS-c-based treatments.

What This Study Doesn't Tell Us

Tested in mice, not people. Mouse metabolism differs from human metabolism, and the APPL1-SIRT1-PGC-1alpha pathway may not work identically in humans. The adiponectin knockout model eliminates all adiponectin, which is more extreme than the reduced levels seen in human obesity. Cell culture experiments used C2C12 mouse myotubes, which may not perfectly replicate human muscle biology.

Questions This Raises

  • ?Can MOTS-c supplementation bypass the need for adiponectin signaling?
  • ?Does this pathway work the same way in humans?
  • ?Could MOTS-c levels serve as a biomarker for metabolic health?

Trust & Context

Key Stat:
APPL1-SIRT1-PGC-1α the complete signaling pathway connecting adiponectin to MOTS-c mitochondrial peptide production
Evidence Grade:
Moderate evidence from mouse and cell culture studies. The pathway is well-mapped mechanistically but not yet confirmed in humans.
Study Age:
Published in 2020. MOTS-c research has expanded significantly, with human studies beginning to explore therapeutic applications.
Original Title:
Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.
Published In:
Diabetologia, 63(12), 2675-2688 (2020)
Database ID:
RPEP-04833

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What is MOTS-c and why is it important?

MOTS-c is a small peptide encoded by mitochondrial DNA. It influences how your body processes sugar and fat. Low MOTS-c is associated with obesity and diabetes, and exercise naturally boosts its production.

Does this mean exercise boosts MOTS-c through adiponectin?

Yes. Exercise increases adiponectin, which signals through APPL1-SIRT1-PGC-1α to boost MOTS-c production in muscle. This is one molecular pathway explaining why exercise improves metabolism.

Read More on RethinkPeptides

Cite This Study

RPEP-04833·https://rethinkpeptides.com/research/RPEP-04833

APA

Guo, Qi; Chang, Bo; Yu, Qiong-Li; Xu, Si-Tong; Yi, Xue-Jie; Cao, Shi-Cheng. (2020). Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.. Diabetologia, 63(12), 2675-2688. https://doi.org/10.1007/s00125-020-05269-3

MLA

Guo, Qi, et al. "Adiponectin treatment improves insulin resistance in mice by regulating the expression of the mitochondrial-derived peptide MOTS-c and its response to exercise via APPL1-SIRT1-PGC-1α.." Diabetologia, 2020. https://doi.org/10.1007/s00125-020-05269-3

RethinkPeptides

RethinkPeptides Research Database. "Adiponectin treatment improves insulin resistance in mice by..." RPEP-04833. Retrieved from https://rethinkpeptides.com/research/guo-2020-adiponectin-treatment-improves-insulin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.